- In April 2025, UK-based Genus achieved a significant milestone by obtaining U.S. FDA approval for its gene-edited pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS). This approval is expected to enhance disease resistance in swine populations and reduce economic losses in the pork industry. Genus is also pursuing regulatory approvals in other major markets, including Canada, Mexico, Japan, and China
- In January 2025, Gemini Genetics, based in Shropshire, UK, offers pet cloning services by collecting DNA samples from pets and coordinating with U.S. laboratories for the cloning process. Despite the high cost of approximately GBP 40,000 per pet, the service has gained attention among pet owners seeking to replicate their beloved animals. The procedure involves somatic cell nuclear transfer to create genetically identical animals
- In May 2024, NB Genetics, an Angus seedstock operation near Chinchilla, Australia, partnered with ABS Global to introduce "NuEra" genetics into their cattle breeding program. This initiative aims to improve carcass quality and production efficiency in Australian beef through advanced genetic technologies. The program involves implanting NuEra T14 male sexed embryos into recipient cows, marking a first in the country
- In June 2022, Zoetis, a global animal health company, acquired Basepaws, a company specializing in pet genetics. This acquisition enhances Zoetis's capabilities in genetic testing and data analytics, allowing for more advanced approaches to animal care and personalized pet health solutions
- In May 2022, Neogen Corporation and Gencove launched InfiniSEEK, an affordable genome sequencing and SNP analysis tool designed for bovines. Capable of assessing over 400 genetic traits and conditions, InfiniSEEK aims to provide comprehensive and cost-effective genetic testing options to enhance livestock management and breeding decisions
